Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider transactions rather than a financial performance report.
Material Changes
The filing details specific transactions by Mr. A P Witty on March 25, 2011:
- Purchase of 861 Ordinary shares within an ISA at a price of £11.70 per share.
- Transfer by way of gift of 500 Ordinary shares to each of his two children.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).
Key Facts for Investor Verification
- Director Mr. A P Witty increased his direct holding by purchasing 861 shares at £11.70.
- Mr. Witty gifted a total of 1,000 shares (500 to each child) on the same date.
- The transactions were notified to the company on March 25, 2011.
- No financial performance data is included in this specific filing.